Topical Photodynamic Therapy (PDT) With Levulan Kerastick for Benign Dermal Neurofibromas Phase II

Trial Profile

Topical Photodynamic Therapy (PDT) With Levulan Kerastick for Benign Dermal Neurofibromas Phase II

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Neurofibroma; Neurofibromatoses
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2017 Last checked against ClinicalTrials.gov record.
    • 03 Aug 2016 Planned End Date changed from 1 Sep 2023 to 1 Aug 2023.
    • 03 Aug 2016 Planned primary completion date changed from 1 Sep 2022 to 1 Aug 2022.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top